Лукавишь окаянный. Ты привёл данные именно фарм-гигантов, ибо ФУВ РГМУ никаких исследований НЕ проводило, а ссылается на следующий список -
Литература
1. Martin B, Keller MD, James H, Kocsis MD, Michael E, Thase MD et
. JAMA 1998; 280: 1665–72. Maintenance Phase Effficacy of Sertraline for Chronic Depression A Randomized Controlled Trial
2. James M, Russell MD, Lorrin M et
. Depression and Anxiety 2001; 13: 18.
3. Moscovitch A, Wiseman RL, Goldberg MS et
. A double-blind, placebo-controlled study o sertraline in the treatment o outpatients with SAD (abstract). Presented at the American Psychiatric Association Meeting; May 24, 1995; Miami Beach, FL.
4. Blashko CA. Biol Psychiatry 1997; 42: 58S–59S.
5. Beham P, Berti C, Doogan DP. Neuropsychopharmacology 1994; 10: 105S.
6. Mazo G. Eur Neuropsychopharmacol 2000; 10 (suppl. 2): S48–S49.
7. Sogaard J, Latimer P et
. J Psychopharmacol 1999; 13: 406–14.
8. Ravindran AV, Gueli JD, Lane RM et
. J Clin Psychiatry 2000; 61: 821–7.
9. Ravindran AV, Anisman H, Merali Z et
. Am J Psychiatry 1999; 156: 1608–17.
10. Browne G, Steiner M, Roberts J et
. J Affect Disord 2002; 68: 317–30.
11. Markowitz JC, Bleiberg KL, Kocsis JH. Treatment strategies for dysthymic disorders (abstract). 155th Annual Meeting of the American Psychiatric Association (APA; May 18–23, 2002; Philadelphia, PA.
12. Hellerstein DJ, Kocsis JH, Chapman D et
. Am J Psychiatry 2000; 157: 1436–44.
13. Nixon MK, Milin R, Simeon JG et
. J Chikd Adolesc Psychopharmacol 2001; 11: 131–42.
14. Thase ME, Fava M, Halbreich U et
. Arch Gen Psychiatry 1996; 53: 777–84.
15. Kocsis JH, Zisook S, Davidson J et
. Am J Psychiatry 1997; 154: 390–5.
16. Lee MS, Dim SH, Suh KY et
. Neuropsychopharmacology 1994; 10: 222S.
17. Bellino S, Barzega G, Bogetto F et
. Curr Ther Res 1997; 58: 798–808.
18. Epperson CN, Ward-O'Brien D, Price LH et
. Soc Neurosci Abst 1996; 22 (1–3): 179.
19. Stowe ZN, Casarella J, Landry J et
. Depression 1995; 3: 49–55.
20. Koran LM, Hackett E, Rubin A et
. Am J Psychiatry 2002; 159: 88–95.
21. Greist JH, Jefferson JW, Kobak KA et
. Int Clin Psychopharmacol 1995; 10: 57–65.
22. Rapaport MH, Wolkow R, Rubin A et
. Acta Psychiatr Scand 2001; 104: 289–98.
23. Londborg PD, Hegel MT, Goldstein S et
. J Clin Psychiatry 2001; 62: 325–31.
24. Rapaport MH, Endicott J, Clary CM. J Clin Psychiatry 2002; 63: 59–65.
25. Brady KT, Sonne SC, Roberts JM. J Clin Psychiatry 1995; 56: 502–5.
26. George R,Sanchez F, Chavez R et
. Impact of sertraline on alcohol consumption in am open clinical trial (poster). Presented at Research Society on Alcoholism Meeting; June 1994; Hawaii.
27. Eggerth D, Walker S, Eilot A et
. Psychosocial impacts of sertraline in alcoholism treatment (abstract). Presented at Research Society on Alcoholism Meeting; June 1994; Hawaii.
28. Pettinati HM, Volpicelli JR, Kranzler HR et
. Alcohol Clin Exp Res 2000; 24 (7): 1041–9.
29. Pettinati HM, Volpicelli JR, Luck G et
. J Clin Psychopharmacol 2001; 21: 143–53.
30. Donnelly CL, Winoker A, Wohlberg CJ. Effficacy and safety of sertraline in the treatment of pediatric major depressive disorder (poster). Presented at American College of Neuropsychopharmacology (ACNP) Annual Meeting; December 9–13, 2001; Waikoloa, Hawaii.
31. McConville BJ, Minnery KL, Sorter MT et
. J Child Adolesc Psychopharmacol 1996; 6 (1): 41–51.
32. Ambrosini PJ, Wagner KD, Biederman J et
. J Am Acad Child Adolesc Psychiatry 1999; 38: 566–72.
33. Tierney E, Joshi PT, Llinas JF et
. J Child Adolesc Psychopharmacol 1995; 5: 13–27.
34. Nixon MK, Milin R, Simeon JG et
. J Child Adolesc Psychopharmacol 2001; 11: 131–42.
35. March JS, Biederman J, Wolkow R et
. JAMA 1998; 280: 1752–6.
36. Johnston HF. The efficacy of sertraline and behavior therapy in adolescents with treatment resistant OCD (abstract). Presented at the 14th Annual Meeting of the American Psychiatric Association; May 23–26, 1993: San Francisco, CA.
37. Lombroso PJ, Scahill L, King RA et
. J Am Acad Child Adolesc Psychiatry 1995; 34: 1147–52.
38. Cook EH, Wagner KD, March JS et
. J Am Acad Child Adolesc Psychiatry 2001; 40: 1175–81.
39. Wilens TE, Biederman J, March JS et
. J Am Acad Child Adolesc Psychiatry 1999; 38: 573–7.
40. El-Khatib HE, Dickey TO III. J Am Acad Chld Adolesc Psychiatry 1995; 34: 1404–5.
41. Glassman AH, Shapiro PA. Am J Psych 1998; 155: 4–11.
42. McFarlane A, Kamath MV, Fallen EL et
. Am Heart J 2001; 142: 617–23.
43. Krishnan KRR, Doraiswany M, Clary C. Prog Neuro-Psychopharmacol & Biol Psychiat 2001; 25: 347–61.
44. Rasmussen A, Lunde M, Sorensen K et
. A duble-blind placebo-controlled study of sertraline in the prevention of depression in stroke patients (poster). Presented at 2002 American Psychiatric Association (APA) Annual Meeting; May 18–23, 2002; Philadelphia, PA.
45. Smoller JW, Pollack MH, Systrom D et
. Psychosomatics 1998; 39: 24–9.
